Anti-SPECC1L-ADORA2A monoclonal antibody

Pre-made anti-SPECC1L-ADORA2A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SPECC1L-ADORA2A/SPECC1L-ADORA2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1807-Ab-1/ GM-Tg-hg-IP1807-Ab-2Anti-Human SPECC1L-ADORA2A monoclonal antibodyHuman
GM-Tg-rg-IP1807-Ab-1/ GM-Tg-rg-IP1807-Ab-2Anti-Rat SPECC1L-ADORA2A monoclonal antibodyRat
GM-Tg-mg-IP1807-Ab-1/ GM-Tg-mg-IP1807-Ab-2Anti-Mouse SPECC1L-ADORA2A monoclonal antibodyMouse
GM-Tg-cynog-IP1807-Ab-1/ GM-Tg-cynog-IP1807-Ab-2Anti-Cynomolgus/ Rhesus macaque SPECC1L-ADORA2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1807-Ab-1/ GM-Tg-felg-IP1807-Ab-2Anti-Feline SPECC1L-ADORA2A monoclonal antibodyFeline
GM-Tg-cang-IP1807-Ab-1/ GM-Tg-cang-IP1807-Ab-2Anti-Canine SPECC1L-ADORA2A monoclonal antibodyCanine
GM-Tg-bovg-IP1807-Ab-1/ GM-Tg-bovg-IP1807-Ab-2Anti-Bovine SPECC1L-ADORA2A monoclonal antibodyBovine
GM-Tg-equg-IP1807-Ab-1/ GM-Tg-equg-IP1807-Ab-2Anti-Equine SPECC1L-ADORA2A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1807-Ab-1/ GM-Tg-hg-IP1807-Ab-2; GM-Tg-rg-IP1807-Ab-1/ GM-Tg-rg-IP1807-Ab-2;
GM-Tg-mg-IP1807-Ab-1/ GM-Tg-mg-IP1807-Ab-2; GM-Tg-cynog-IP1807-Ab-1/ GM-Tg-cynog-IP1807-Ab-2;
GM-Tg-felg-IP1807-Ab-1/ GM-Tg-felg-IP1807-Ab-2; GM-Tg-cang-IP1807-Ab-1/ GM-Tg-cang-IP1807-Ab-2;
GM-Tg-bovg-IP1807-Ab-1/ GM-Tg-bovg-IP1807-Ab-2; GM-Tg-equg-IP1807-Ab-1/ GM-Tg-equg-IP1807-Ab-2
Products NameAnti-SPECC1L-ADORA2A monoclonal antibody
Formatmab
Target NameSPECC1L-ADORA2A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SPECC1L-ADORA2A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1807-Ag-1Recombinant multi-species SPECC1L-ADORA2A protein


    Target information

    Target IDGM-IP1807
    Target NameSPECC1L-ADORA2A
    Gene ID101730217
    Gene Symbol and SynonymsSPECC1L-ADORA2A
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000258555
    Target ClassificationN/A

    The target: SPECC1L-ADORA2A, gene name: SPECC1L-ADORA2A, also named as . This locus represents naturally occurring readthrough transcription between the neighboring SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) genes on chromosome 22. The readthrough transcript is a candidate for nonsense-mediated mRNA decay (NMD) and is unlikely to produce a protein product. [provided by RefSeq, Jun 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.